Foley Hoag LLP announced that well-known patent litigator Donald R. Ware became chair of the firm's expanded Intellectual Property Group and Dana Gordon, a registered patent attorney and scientist, became deputy chair.

The reorganized and expanded IP Group combines several historically strong disciplines in the firm and brings them under one umbrella. The IP Group, comprised of over 80 professionals, includes lawyers, scientists, engineers, medical doctors and other practitioners experienced in patent prosecution, patent litigation, technology transfer, IP due diligence and strategies, copyright and trademark prosecution, and trade secret litigation.

"We know our clients want efficiency, responsiveness, and a broad knowledge of cutting-edge technology issues. They want their lawyers to be immersed in their business and industry and to understand all aspects of their intellectual property needs, " said Donald R. Ware, chair of the practice. "Our multi-disciplinary approach allows us to serve our clients in a more powerful and synergistic way."

"The breadth and depth of our IP Group allow us to help clients shape an intellectual property strategy to gain a competitive advantage in the marketplace," said deputy chair Dana M. Gordon. "That capability is particularly important in the biotechnology and pharmaceutical industries, areas in which we are deeply rooted."

Don, also a former member of the firm's Executive Committee, specializes in biomedical patent litigation including recombinant DNA, monoclonal antibodies, small molecule compounds, drug delivery, molecular diagnostics, research tool patents, and medical devices. He represents some of the world's leading biotechnology companies and academic institutions. Don has been recognized as a leading IP lawyer in Best Lawyers in America®, Chambers USA: the Client's Guide, PLC Which Lawyer? and Global Counsel 3000. He holds his undergraduate degree from Yale University and his law degree from Harvard University. For more information, click here.

Dana is a registered patent attorney, handling matters involving organic chemistry, including synthetic organic chemistry, pharmaceuticals, molecular diversity, materials science, biochemistry and molecular biology. His client list includes many of the country's leading academic and private research institutions. Dana holds a Ph.D. in Organic Chemistry from Yale University, and his law degree from Boston College Law School. For more information, click here.

Foley Hoag has long been a presence in the IP area, having served clients in the technology and life sciences industries for decades.  In 2006, the firm launched its Emerging Enterprise Center, located in the heart of New England's "Technology Corridor" to focus on the unique needs - including intellectual property - of the entrepreneurial community.  The IP practice is consistently ranked among top firms by leading publications such as Chambers USA and Legal 500.

About Foley Hoag

Foley Hoag provides comprehensive legal services to clients throughout the United States and around the world. We serve a wide range of industries including biopharma, energy and utilities, financial services, manufacturing, and technology. With 250 lawyers located in Boston, Washington, DC, and the Emerging Enterprise Center in Waltham, MA, we provide creative solutions and results-oriented advice in the areas of bankruptcy, restructuring and workouts; corporate finance, mergers and acquisitions, and IPOs; labor and employment; litigation; environmental issues and land use; government strategies; intellectual property; tax, trusts and estates; and white collar and business crimes.

For more information, visit www.foleyhoag.com.